)
)
EQRx Investor Relations Material
Latest events
Q1 2023
EQRx
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from EQRx Inc
Access all reports
EQRx, Inc. is a biotechnology company focused on developing and delivering innovative medicines at more affordable prices. The company aims to address the high cost of drugs by re-engineering the drug discovery and development process, creating therapies for conditions such as cancer and immune-inflammatory diseases. EQRx seeks to offer high-quality treatments that are more accessible to healthcare systems and patients. The company collaborates with global partners to advance its drug pipeline while leveraging advanced technologies to expedite drug development and reduce costs. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
EQRX
Country
🇺🇸 United States